Personalized risk-based colorectal cancer screening would be ideal, but we may not yet be ready for such an approach. Find out why in this EBM Focus.
EBM Focus: A Protoscopy of the New Colorectal Cancer Screening Guideline
November 14, 2019
A new study evaluates personalized stratification of the net benefit or harm of aspirin for primary prevention of cardiovascular disease (CVD).
EBM Focus: PREDICTing the Net Benefit of Aspirin for Primary Prevention
November 12, 2019
Point-of-care C-reactive protein (CRP) testing may allow for more judicious use of antibiotics in patients with an acute COPD exacerbation.
EBM Focus: CRP-guided Antibiotic Therapy for Acute Exacerbations of COPD
November 06, 2019
Read about a new trial showing noninferiority of oral semaglutide for cardiovascular outcomes in patients with type 2 diabetes.
EBM Focus: Oral Semaglutide May Be Safe for Those at High Cardiovascular Risk
November 04, 2019
There is still so much to understand about E-cigarette or Vaping product use Associated Lung Injury (EVALI). Here’s what we know.
E-cigarette or Vaping Product Use Associated Lung Injury (EVALI): What Do We Know?
October 24, 2019
If you live in New England or Michigan, chances are you’re hearing a lot about Eastern Equine Encephalitis (EEE). Here’s what physicians need to know.
What You Need to Know About Triple E — Eastern Equine Encephalitis (EEE)
October 02, 2019
Driving low density lipoprotein cholesterol (LDL-C) as low as possible seems to be the mindset of many clinicians and patients these days. But how low is too low?
EBM Focus: Low LDL Cholesterol May Be Associated with Intracerebral Hemorrhage
September 30, 2019
Two new studies investigate shorter duration of DAPT after stent placement in patients at low-intermediate risk of bleeding. Read more in the latest EBM Focus.
EBM Focus: Don’t overDAPT it – One Month May Be Enough After Stent Placement for Low-Risk Patients
August 29, 2019
A new study evaluated self-reported cannabis use in pregnancy and maternal, perinatal, and neonatal outcomes. Read more in the latest EBM Focus.
EBM Focus: Antenatal Cannabis Use May Increase Risk of Preterm Delivery
August 06, 2019
Aflibercept may not be worth the cost for patients with diabetic macular edema and good visual acuity. Read more in the latest EBM Focus.
EBM Focus: Aflibercept for Diabetic Macular Edema with Preserved Visual Acuity — Seeing Dollar Signs
July 29, 2019
© 2019 EBSCO Industries, Inc. All rights reserved